MethylDetect
Private Company
Funding information not available
Overview
MethylDetect ApS is a Copenhagen-based provider of epigenetic research tools, specializing in DNA methylation analysis. The company's core product line, EpiMelt, includes ready-to-use methylation detection assays, a real-time PCR master mix, and bisulfite modification kits, all centered on making MS-HRM technology accessible. Targeting academic and industrial researchers, MethylDetect operates in the growing field of epigenetic diagnostics, with applications spanning cancer, neurological disorders, and other complex diseases. It appears to be a private, early-revenue stage company leveraging a mix of off-the-shelf kits and custom assay development services.
Technology Platform
Methylation Sensitive High Resolution Melting (MS-HRM) technology packaged into ready-to-use EpiMelt kits, including gene-specific assays, a real-time PCR master mix, and bisulfite modification kits.
Opportunities
Risk Factors
Competitive Landscape
MethylDetect competes in the niche market of DNA methylation analysis reagents against larger life science tools companies (e.g., Qiagen, Thermo Fisher) that offer alternative technologies like pyrosequencing kits, as well as against service providers and the trend towards broader, NGS-based epigenetic profiling.